What is the recommended management and antibiotic dosing for community‑acquired pneumonia in an otherwise healthy child, including outpatient oral therapy, criteria for hospitalization, and inpatient IV regimens?

Management of Pediatric Community-Acquired Pneumonia

Outpatient Oral Therapy

For otherwise healthy children with uncomplicated community-acquired pneumonia, amoxicillin 90 mg/kg/day divided into 2 doses (or 45 mg/kg/day in 3 doses) is the first-line treatment, with a duration of 3-5 days being sufficient. 1

• Amoxicillin provides optimal coverage for Streptococcus pneumoniae, the most common bacterial pathogen in pediatric CAP 1
• Maximum daily dose considerations apply based on local resistance patterns 1
• Recent evidence from high-income countries supports short-course therapy (3-5 days) for uncomplicated cases, representing a shift from traditional 7-10 day courses 2, 3
• Treatment duration should not exceed 7 days even when using traditional approaches 3

Alternative Oral Agents

• For penicillin-allergic patients: Second- or third-generation cephalosporins (cefpodoxime, cefuroxime, cefprozil) 1
• For atypical pathogen coverage (Mycoplasma pneumoniae, Chlamydophila pneumoniae) in school-aged children and adolescents: Add azithromycin (10 mg/kg on day 1, then 5 mg/kg days 2-5) 1
• Prompt penicillin allergy de-labeling is critical to avoid unnecessary broad-spectrum antibiotics 2

---

Criteria for Hospitalization

Admit children who demonstrate any of the following:

• Hypoxemia (oxygen saturation <90-92% on room air) 3
• Significant respiratory distress including grunting, severe retractions, or inability to maintain adequate oral intake 3
• Moderate-to-severe dehydration or inability to tolerate oral medications 3
• Failure to improve clinically within 48-72 hours of outpatient antibiotic therapy 3
• Complicated pneumonia including empyema, necrotizing pneumonia, or lung abscess 1
• Suspected Staphylococcus aureus infection, particularly in the context of influenza or severe presentation 1

---

Inpatient IV Antibiotic Regimens

First-Line Therapy for Uncomplicated CAP

Ampicillin 150-200 mg/kg/day divided every 6 hours is the preferred initial IV therapy for hospitalized children with uncomplicated CAP. 1, 4

• Ampicillin provides excellent coverage for S. pneumoniae with penicillin MICs ≤2.0 μg/mL 1
• Implementation of ampicillin-first protocols has shown 34% increase in appropriate narrow-spectrum use without increased treatment failure 4
• Alternative: IV penicillin G 200,000-250,000 units/kg/day divided every 4-6 hours 1

When to Use Broader Spectrum Therapy

Ceftriaxone 50-100 mg/kg/day divided every 12-24 hours (or cefotaxime 150 mg/kg/day every 8 hours) should be used when:

• High-level penicillin-resistant S. pneumoniae is suspected (MIC ≥4.0 μg/mL) based on local epidemiology 1
• Life-threatening infection or empyema is present 1
• Patient has failed initial ampicillin therapy 1

Addition of Atypical Coverage

Add IV azithromycin (10 mg/kg on days 1-2, then 5 mg/kg daily) or oral macrolide to β-lactam therapy when:

• School-aged children or adolescents where M. pneumoniae or C. pneumoniae are significant considerations 1
• Perform diagnostic testing if available in clinically relevant timeframe 1

Coverage for Staphylococcus aureus

Add vancomycin 40-60 mg/kg/day divided every 6-8 hours (or dosing to achieve AUC/MIC >400) or clindamycin 40 mg/kg/day divided every 6-8 hours when:

• Community-acquired MRSA is suspected (particularly post-influenza, necrotizing pneumonia, or empyema) 1
• Local susceptibility data should guide clindamycin use for MRSA 1

For methicillin-susceptible S. aureus:

• Cefazolin 150 mg/kg/day every 8 hours or oxacillin 150-200 mg/kg/day every 6-8 hours 1

---

Transition to Oral Therapy and Discharge

Switch from IV to oral antibiotics when the child is:

• Clinically improving (decreased fever, improved respiratory effort) 3
• Able to tolerate oral intake 3
• Hemodynamically stable without supplemental oxygen requirement 3

Discharge Oral Antibiotics

• Amoxicillin 90 mg/kg/day in 2 doses for step-down from ampicillin/penicillin 1, 4
• Avoid unnecessary broad-spectrum agents like cefdinir or amoxicillin-clavulanate when narrow-spectrum options are appropriate 4
• Complete a total antibiotic course of 3-5 days for uncomplicated cases 2, 5

---

Special Pathogen-Specific Dosing

Haemophilus influenzae (typeable or nontypeable)

• IV: Ampicillin 150-200 mg/kg/day every 6 hours if β-lactamase negative; ceftriaxone 50-100 mg/kg/day if β-lactamase producing 1
• Oral: Amoxicillin 75-100 mg/kg/day in 3 doses if β-lactamase negative; amoxicillin-clavulanate (amoxicillin component 45-90 mg/kg/day) if β-lactamase producing 1

Group A Streptococcus

• IV: Penicillin G 100,000-250,000 units/kg/day every 4-6 hours or ampicillin 200 mg/kg/day every 6 hours 1
• Oral: Amoxicillin 50-75 mg/kg/day in 2 doses or penicillin V 50-75 mg/kg/day in 3-4 doses 1

---

Common Pitfalls to Avoid

• Overuse of broad-spectrum antibiotics: Ceftriaxone should not be routine first-line therapy for uncomplicated CAP; ampicillin is equally effective and reduces resistance pressure 4
• Prolonged IV therapy: Early IV-to-oral switch (within 24-48 hours of clinical improvement) is safe and reduces hospitalization costs without compromising outcomes 6, 7
• Excessive treatment duration: Extending antibiotics beyond 5-7 days for uncomplicated CAP provides no additional benefit and increases adverse effects 2, 3
• Routine chest radiography: Only obtain if diagnosis is uncertain, hypoxemia present, or clinical failure at 48-72 hours 3
• Ignoring local resistance patterns: Antibiotic selection must account for regional S. pneumoniae resistance and MRSA prevalence 1